The Pharmaceutical Care Management Association, which represents PBM's, called the FTC report baseless and "without ...

The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs ...

The "Big 3" PBMs also separately generated an estimated $1.4 billion of income from spread pricing, FTC finds.

An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.

CVS Caremark, OptumRx and St. Louis-based Express Scripts — are part of huge health conglomerates that also own insurers, ...

WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...

Pharmacy benefit managers "are raking in billions in excess revenue—$7.3 billion over just five years—while squeezing ...

Report reveals big pharma middlemen inflating drug prices, reaping billions in excess revenue. • The Federal Trade Commission (FTC) released a report showing that pharmacy benefit managers (PBMs) ...

The report is the latest indictment of America’s broken healthcare system.

"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...

FTC report reveals significant markups by top PBMs on specialty drugs, driving $7.3 billion in revenue and raising costs for ...